Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Meeting of the Anti-Infective Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

December 14-15, 2006

John Bartlett, M.D.

• 18 U.S.C. 208 waiver [pdf] (Updated 12/12/2006)
• Acknowledgement and Consent [pdf]

John Bradley, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Jennifer Dunbar, M.D. (Not attending)

• Acknowledgement and Consent [pdf]

John Edwards, Jr., M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Carol Koski, M.D.

• Acknowledgement and Consent [pdf]

Louis Morris, Ph.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Carl Norden, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Page updated: December 12, 2006